Dr Philip Savage

Dr Savage trained in Medicine in Bristol. Dr Savage also trained in Medical Oncology at the Royal Marsden and Imperial Hospitals. Dr Savage was a Consultant at Charing Cross Hospital for ten years, where they were clinical lead for testicular cancer, urology oncology, chemotherapy and acute oncology. Following a career sabbatical with the BCCA in Canada, they returned to the UK to practice. Dr Savage has a strong research interest and has over 150 medical and scientific publications. Alongside this, they have extensive experience in clinical care of patients with urological malignancies.

Dr Savage trained in Medical Oncology at the Royal Marsden and Imperial Hospitals and was for many years a Consultant at Charing Cross Hospital in London where they were the lead clinician for chemotherapy and urology oncology. Following a career break in Vancouver Island, Canada, working for the British Columbia Cancer Agency, Dr Savage returned to the UK. Dr Savage has a specialist interest in the management of urology malignancies and also in rare malignancies.

Dr Savage obtained a PhD in the immunotherapy of cancer and has retained an ongoing activity in this area. They have worked closely with a number of biotechnology and pharmaceutical companies on both immunotherapy and cancer gene therapy projects. More recently, Dr Savage has worked on a new approach to chemotherapy sensitivity and resistance of cancer cells and exploring the potential for novel approaches to therapy. Alongside these laboratory-based projects, Dr Savage has also published several papers looking at clinical research predominantly in gynaecology oncology and uro-oncology.